← Evidence map

ArticleiScience2026

A phase III clinical trial of PXT3003 in Chinese patients with Charcot-Marie-Tooth disease type 1A.

Xiaoxuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42699772